Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Zecevic, Zeljko (36019685900)"

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Complex karyotype with cryptic FUS gene rearrangement and deletion of NR3C1 and VPREB1 genes in childhood B-cell acute lymphoblastic leukemia: A case report
    (2020)
    Othman, Moneeb A.K. (55847257000)
    ;
    Đurišić, Marina (56574126700)
    ;
    Samardzija, Gordana (56177152500)
    ;
    Vujić, Dragana (16647611700)
    ;
    Lakic, Nina (35386377100)
    ;
    Zecevic, Zeljko (36019685900)
    ;
    Al-Shaheri, Fawaz (57194229046)
    ;
    Aroutiounian, Rouben (24597040000)
    ;
    Melo, Joana B. (57980837900)
    ;
    Carreira, Isabel M. (55915636100)
    ;
    Meyer, Britta (57198566527)
    ;
    Liehr, Thomas (56404741200)
    B-cell acute lymphoblastic leukemia (B-ALL) is a hematopoietic malignancy characterized by overproduction of immature B-lymphoblasts. B-ALL is the most common pediatric tumor and remains the leading cause of mortality in children and adolescents. Molecular and cytogenetic analyses of B-ALL revealed recurrent genetic and structural genomic alterations which are routinely applied for diagnosis, prognosis and choice of treatment regimen. The present case report describes a 4-year-old female diagnosed with B-ALL. GTG-banding at low resolution revealed an abnormal clone with 46,XX,?t(X;19)(q13;q13.3),der(9) besides normal cells. Molecular cytogenetics demonstrated a balanced translocation between chromosomes 16 and 19, and an unbalanced translocation involving chromosomes 5 and 9. A locus-specific probe additionally identified that the FUS gene in 16p11.2 was split and its 5' region was translocated to subband 19q13.33, whereas the 3' region of the FUS gene remained on the derivative chromosome 16. Overall, this complex karyotype included four different chromosomes and five break events. Further analyses, including array-comparative genomic hybridization, additionally revealed biallelic deletion of the tumor suppressor genes CDKN2A/B, and deletion of the NR3C1 and VPREB1 genes. The patient passed away under treatment due to sepsis. © 2020 Spandidos Publications. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Complex karyotype with cryptic FUS gene rearrangement and deletion of NR3C1 and VPREB1 genes in childhood B-cell acute lymphoblastic leukemia: A case report
    (2020)
    Othman, Moneeb A.K. (55847257000)
    ;
    Đurišić, Marina (56574126700)
    ;
    Samardzija, Gordana (56177152500)
    ;
    Vujić, Dragana (16647611700)
    ;
    Lakic, Nina (35386377100)
    ;
    Zecevic, Zeljko (36019685900)
    ;
    Al-Shaheri, Fawaz (57194229046)
    ;
    Aroutiounian, Rouben (24597040000)
    ;
    Melo, Joana B. (57980837900)
    ;
    Carreira, Isabel M. (55915636100)
    ;
    Meyer, Britta (57198566527)
    ;
    Liehr, Thomas (56404741200)
    B-cell acute lymphoblastic leukemia (B-ALL) is a hematopoietic malignancy characterized by overproduction of immature B-lymphoblasts. B-ALL is the most common pediatric tumor and remains the leading cause of mortality in children and adolescents. Molecular and cytogenetic analyses of B-ALL revealed recurrent genetic and structural genomic alterations which are routinely applied for diagnosis, prognosis and choice of treatment regimen. The present case report describes a 4-year-old female diagnosed with B-ALL. GTG-banding at low resolution revealed an abnormal clone with 46,XX,?t(X;19)(q13;q13.3),der(9) besides normal cells. Molecular cytogenetics demonstrated a balanced translocation between chromosomes 16 and 19, and an unbalanced translocation involving chromosomes 5 and 9. A locus-specific probe additionally identified that the FUS gene in 16p11.2 was split and its 5' region was translocated to subband 19q13.33, whereas the 3' region of the FUS gene remained on the derivative chromosome 16. Overall, this complex karyotype included four different chromosomes and five break events. Further analyses, including array-comparative genomic hybridization, additionally revealed biallelic deletion of the tumor suppressor genes CDKN2A/B, and deletion of the NR3C1 and VPREB1 genes. The patient passed away under treatment due to sepsis. © 2020 Spandidos Publications. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Monitoring of pediatric patients with malignant hematological diseases after allogeneicHSCT: Serbian experience
    (2012)
    Krstic, Aleksandra Drago (56781196900)
    ;
    Stojkovic, Oliver (35618950700)
    ;
    Guc-Scekic, Marija (6602359789)
    ;
    Jevtic, Dragana (29467561400)
    ;
    Zecevic, Zeljko (36019685900)
    ;
    Vujic, Dragana Stojan (16647611700)
    We describe the implementation of short tandem repeats-polymerase chain reaction (STR-PCR) chimerism analyses coupled with reverse transcription PCR detection of recurrent translocations characteristic for childhood leukemia in monitoring of patients after allogeneic hematopoietic stem cell transplantation in Serbia and the first clinical results thereof. Chimerism and minimal residual disease were regularly analyzed from blood and marrow samples of 26 pediatric patients taken after stem cell transplantation with a median follow-up of 17.6 months. Our results demonstrate that STR-based chimerism monitoring is sufficient in establishing the origin of engrafted cells after transplantation and in detecting graft rejection, but more specific and more sensitive method is necessary for identifying patients with threatening leukemia relapse. Copyright © 2012 by Lippincott Williams & Wilkins.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback